ROBERT WILLIAM HANDER
Pilots at Pne Ter Ln, Spokane Valley, WA
License number
Washington A4345171
Issued Date
Dec 2015
Expiration Date
Dec 2017
Category
Airmen
Type
Authorized Aircraft Instructor
Address
Address
2311 S Pne Ter Ln, Spokane Valley, WA 99019
Professional information
Dr. Robert W Hander - MD (Doctor of Medicine)
Hospitals:
12120 E Mission Ave STE 2, Spokane Valley 99206
Valley Hospital
12606 East Mission Ave, Spokane Valley 99216
12120 E Mission Ave STE 2, Spokane Valley 99206
Valley Hospital
12606 East Mission Ave, Spokane Valley 99216
Valley Hospital
12606 East Mission Ave, Spokane Valley 99216
12120 E Mission Ave STE 2, Spokane Valley 99206
Valley Hospital
12606 East Mission Ave, Spokane Valley 99216
Education:
Medical Schools
University of Medicine And Dentistry of New Jersey / Newark
Graduated: 1977
University of Medicine And Dentistry of New Jersey / Newark
Graduated: 1977
Robert W Hander, Spokane Valley WA
Specialties:
Ophthalmologist
Address:
12120 E Mission Ave, Spokane Valley, WA 99206
Education:
University of Medicine and Dentistry of New Jersey, New Jersey Medical School - Doctor of Medicine*
Board certifications:
American Board of Ophthalmology Certification in Ophthalmology*
Enhancement Of Urogenital Function
US Patent:
8513306, Aug 20, 2013
Filed:
Dec 23, 2010
Appl. No.:
12/978312
Inventors:
Robert W. Hander - Spokane Valley WA, US
International Classification:
A01N 33/02
US Classification:
514565
Abstract:
A method of treating nocturia in a human individual includes administering dosages of creatine to the individual; and reducing the dosages of creatine to the individual responsive to an increase in difficulty of the individual to initiate urination. Another example method includes reducing the dosages of creatine to the individual responsive to an increase in nocturnal urination frequency of the individual. A dosing system includes doses of creatine for treating nocturia in a human individual and is configured for reduced doses for administration in response to an increase in one or more nocturia symptoms. Various other methods as well as compositions, systems, etc. , are also disclosed.
Enhancement Of Urogenital Function
US Patent:
2007015, Jul 5, 2007
Filed:
Dec 28, 2006
Appl. No.:
11/617601
Inventors:
Robert Hander - Spokane Valley WA, US
International Classification:
A61K 31/205, A61K 31/203, A61K 31/202, A61K 31/13
US Classification:
514554000, 514560000, 514662000
Abstract:
An exemplary method of treating a urologic symptom includes administering a daily dose of creatine monophosphate (a phosphorylated creatine) to an individual wherein the daily dose of creatine monophosphate lies in a range from about 0.4 mg to about 4.0 mg per kilogram body weight. Such an exemplary method may further include administering a dose of a compound that inhibits phosphodiesterase (e.g., at a time less than approximately 4 hours prior to sexual activity). Other exemplary methods, compounds, compositions, etc., are also disclosed.